Search - tctmd.com

Displaying 341 - 360 of 392

Sort: Relevancy | Date

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Daily News

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Caitlin E. Cox

April 26, 2013

News Daily News

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

April 12, 2013

News Daily News

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

April 12, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Daily News

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Jason Kahn

January 28, 2013

News Daily News

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Caitlin E. Cox

January 16, 2013

News Industry News

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

October 29, 2012

News Conference News TCT 2012

Registries Show TAVR Evolution in UK, Internationally

October 24, 2012

Presentation TCT 2012

Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation

Presenter: Raj Makkar

October 24, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

Presentation TCT 2012

Reduces Paravalvular Regurgitation

Presenter: Benoit Daneault

October 22, 2012

Presentation TCT 2012

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

News Industry News

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

October 10, 2012

News Conference News ESC 2012

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Caitlin E. Cox

August 28, 2012

News Conference News ESC 2012

Predictors of Aortic Regurgitation After TAVR Delineated

August 26, 2012

Advertisement

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

Registries Show TAVR Evolution in UK, Internationally

Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Reduces Paravalvular Regurgitation

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Predictors of Aortic Regurgitation After TAVR Delineated

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content